We are live on ! Find out more

363 hedge funds and large institutions have $12.7B invested in DexCom in 2018 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 96 increasing their positions, 131 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

441% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 17

43% more capital invested

Capital invested by funds: $8.85B → $12.7B (+$3.84B)

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

26% more funds holding

Funds holding: 289363 (+74)

10% less call options, than puts

Call options by funds: $73.8M | Put options by funds: $81.6M

21.48% less ownership

Funds ownership: 423.38%401.9% (-21%)

27% less repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 131

Holders
363
Holders Change
+74
Holders Change %
+25.61%
% of All Funds
8.3%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.16%
New
92
Increased
96
Reduced
131
Closed
17
Calls
$73.8M
Puts
$81.6M
Net Calls
-$7.8M
Net Calls Change
-$13.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$102M +$34M +1,095,532 +62%
Artisan Partners
27
Artisan Partners
Wisconsin
$102M +$5.92M +191,000 +7%
Goldman Sachs
28
Goldman Sachs
New York
$101M -$12.6M -407,792 -13%
CCI
29
Columbus Circle Investors
$101M +$21.4M +689,032 +32%
GGHC
30
Gilder Gagnon Howe & Co
New York
$100M +$12.9M +415,028 +17%
Mackenzie Financial
31
Mackenzie Financial
Ontario, Canada
$96.7M -$42.2M -1,362,472 -34%
Wells Fargo
32
Wells Fargo
California
$94.6M +$74.3M +2,396,432 +963%
FAM
33
Fred Alger Management
New York
$93.9M +$2.41M +77,816 +3%
Renaissance Technologies
34
Renaissance Technologies
New York
$83.4M +$23.8M +767,664 +49%
Jennison Associates
35
Jennison Associates
New York
$74.4M -$13M -418,540 -17%
Victory Capital Management
36
Victory Capital Management
Texas
$71.9M +$1.07M +34,628 +2%
HM
37
HealthCor Management
New York
$67.9M -$17.4M -559,800 -23%
Rockefeller Capital Management
38
Rockefeller Capital Management
New York
$67.8M -$52.1M -1,681,192 -47%
TCM
39
TimesSquare Capital Management
New York
$66.3M +$57.5M +1,854,800 New
CLOS
40
Compagnie Lombard Odier SCmA
Switzerland
$65.5M -$18.4M -594,952 -25%
Point72 Asset Management
41
Point72 Asset Management
Connecticut
$65M -$95.6M -3,084,708 -63%
Federated Hermes
42
Federated Hermes
Pennsylvania
$64.9M -$799K -25,772 -1%
Franklin Resources
43
Franklin Resources
California
$63.4M -$48.8M -1,575,380 -47%
Northern Trust
44
Northern Trust
Illinois
$61.9M -$2.33M -75,180 -4%
FCM
45
Frontier Capital Management
Massachusetts
$61.1M -$29.2M -943,048 -36%
BM
46
Bridger Management
New York
$57.1M -$33.7M -1,087,104 -41%
ACH
47
ArrowMark Colorado Holdings
Colorado
$54.2M -$45.9M -1,480,148 -49%
Capital Research Global Investors
48
Capital Research Global Investors
California
$51.5M +$44.6M +1,440,000 New
Lord, Abbett & Co
49
Lord, Abbett & Co
New Jersey
$50.9M +$44.1M +1,422,952 New
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$50M -$3.68M -118,740 -8%

DXCM Hedge Fund Activity: Q3 2018 in Review

363 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2018, worth a combined $12.7B — up 43% from $8.85B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new DXCM positions and 17 closed out — a net gain of 75 holders — while 96 added to existing stakes and 131 trimmed.

The largest buyer was Capital International Investors, opening a new position worth an estimated $413M. The largest seller was Capital World Investors, cutting an estimated $523M.

  • 363 institutional investors held DexCom (DXCM) as of Q3 2018, up from 289 in Q2 2018.
  • Funds reported $12.7B of DexCom stock for Q3 2018, up 43% quarter-over-quarter.
  • 92 funds opened new DexCom positions in Q3 2018 and 17 closed out, a net change of +75 holders.
  • The largest DexCom buyer in Q3 2018 was Capital International Investors, an estimated $413M added.
  • The largest DexCom seller in Q3 2018 was Capital World Investors, an estimated $523M sold.

Based on aggregated 13F filings for Q3 2018.